NASDAQ: IRON
Disc Medicine, Inc.
Healthcare · Biotechnology
Market Cap
$3.03B
52w High
$99.50
52w Low
$40.00
P/E
-11.95
Volume
51.64K
Outstanding Shares
38.39M
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 29.85% over the last year. Free cash flow declined 45.76% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
A decisive shift in revenue or cash flow over the next period would be the clearest signal to resolve the ambiguity.
Company profile
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company.
Valuation
Stock splits
Every 10 shares became 1
Profitability & growth
Analyst consensus
11
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q4 FY26 · EPS est -$1.64 · Revenue est $1.88M
View